Nancy S. Berg

Nancy S. Berg is chief executive officer (CEO) and executive director of ISPOR, the leading global professional society for health economics and outcomes research. Ms. Berg has more than 30 years of experience in healthcare and scientific/technical association leadership. She has been an entrepreneur and business consultant to both commercial and nonprofit organizations. At ISPOR, Ms. Berg is responsible for the Society’s global strategic direction and leadership. She has led the organization, in concert with the board of directors, to design and implement a new strategic plan, mission, and vision to guide the Society into the future.

Previously, Ms. Berg led the International Society for Pharmaceutical Engineering (ISPE) as president and CEO. ISPE is the world's largest professional society fostering dialogue and education on technical, scientific, and regulatory best practices in the pharmaceutical and biotech industries. During her tenure with ISPE, Ms. Berg was the architect of the Society's strategic plan, focusing ISPE's energies and expertise on high-value initiatives related to drug shortages, quality metrics, global manufacturing quality, facility, and supply chain issues, and patient experiences in clinical trials. Prior to her role at ISPE, Ms. Berg served as executive director and CEO of the Society of Manufacturing Engineers (SME). She also previously founded a strategic and business development consultancy company.